BCL2 and hydrops fetalis: Additionally, left ventricular assist device (LVAD) therapy reverses the imbalance of the Bcl-2/Bax ratio in patients with HF, supporting the pathological role of MAMs in HF progression (144) (Supplementary Table S1).